Document:

EXHIBIT 10.14

IBM
ISV & DEVELOPER RELATIONS
--------------------------------------------------------------------------------

                              ISV TEAMING AGREEMENT

This is an ISV Teaming Agreement ("Agreement") between TurboWorx, Inc. and
International Business Machines Corporation ("IBM"). Under the terms of this
Agreement, each of us will commit to specific responsibilities for enabling and
marketing your products on an IBM platform(s). The purpose of this Agreement is
for both parties to be more successful by jointly marketing the Solution to
customers. Each party will sell or license its Solution components to customers
under its own terms and conditions. No royalties or fees are paid by either
party to the other for recognized sales of the products or solutions components.

The following are related agreements between the parties which remain in full
force and effect and remain unmodified by this Agreement unless expressly stated
herein:

     1. IBM PartnerWorld Agreement - International Basic General Terms

The complete Agreement between the parties consists of this Agreement and the
following Attachments and Exhibits. If there is a conflict among the terms of
this Agreement and any of its Attachments, the terms of the Attachment prevail:

     Exhibit A - Joint Account List

This Agreement is intended to build upon your existing PartnerWorld
relationship. It complements the IBM PartnerWorld Agreement - International
Basic General Terms already in place between us that you acknowledge executing
when you first joined or registered for PartnerWorld. This Agreement replaces
all prior oral or written communications between the parties relating to this
marketing relationship. Neither party has relied on any promises, inducements
nor representations by the other, except those expressly stated in this
Agreement. Both parties accept the terms of this Agreement by signing below.
Once signed, any reproduction of this Agreement made by reliable means (for
example, photocopy or facsimile) is considered an original, unless prohibited by
local law. This Agreement may only be modified by a writing signed by both
parties.

AGREED TO:                                  AGREED TO:
International Business Machines             TurboWorx, Inc.
Corporation

By:                                         BY:
    ---------------------------------          ---------------------------------

 Jon E. Regitsky                            Srini Chari
-------------------------------------       ------------------------------------
Print Name                                  Print Name

                                            VP and General Manager Solutions
-------------------------------------       ------------------------------------
Print Title                                 Print Title

-------------------------------------       ------------------------------------
Date                                        Date

Any notice required or permitted under this Agreement will be sent to the
representative named below, and shall be effective upon receipt as demonstrated
by reliable written confirmation (for example, certified mail receipt, courier
receipt, facsimile receipt confirmation sheet.) Each party will notify the other
if their representative changes.

<TABLE>
<S>                                            <C>
IBM's Contract Representative:                 TurboWorx's Contract Representative:
International Business Machines Corporation    TurboWorx, Inc.
4111 Northside Parkway, Rm. 11E16              3 Enterprise Drive
Atlanta, GA 30327                              Shelton, CT 06484
Attention: Joseph Jackson                      Attention:  Srini Chari
Phone: 404-238-3194                            Phone: 203 944-0460 Ext. 402
</TABLE>

                                       1
<PAGE>

1.0 DEFINITIONS - Capitalized terms in this Agreement have the following
meaning:

1.1 ENABLE means that your Product takes sufficient advantage of the specified
IBM middleware, software and/or hardware in the Solution (as defined below) to
provide at least equivalent performance and functionality to your Product when
used with non-IBM hardware and/or software, and in the case of Linux, with
non-Linux operating systems.

1.2 GENERAL AVAILABILITY (GA) means the date on which the Enabled version of
your Products and its related end-user documentation are first made commercially
available through direct end-user marketing channels. Delivery of pre-release
copies on a fee or non-fee basis to end-users, independent software vendors or
systems manufacturers for testing or adaptation purposes does not constitute
Generally Availability.

1.3 ENABLED PRODUCT is the Enabled and GA version of your Product.

1.4 PRODUCTS are your software applications entitled "TurboWorx Enterprise" and
"ClusterManager." This includes enhancements, updates, fixes, and new versions
of your Product or any other of your software applications that replace your
existing Products.

1.5 SOLUTION is an e-business on demand offering consisting of your Enabled
Products with IBM's zSeries, iSeries, xSeries, and pSeries hardware platforms,
related operating systems, storage devices, DB2, WebSphere Application Server
and TSpaces middleware or software, all successor versions of these products and
services provided by IBM Global Services.

1.6 JOINT ACCOUNT LIST shall mean a list prepared by you and IBM which
identifies the customers to whom both parties agree to market the Solution. Such
list shall include, without limitation, the customer name and address, each
party's account representative (s) assigned to the account, a description of and
the estimated size of the opportunity and the opportunity's IBM technology
components.

2.0 TERRITORY - The Territory for this Agreement shall consist of all the
countries in the world in which IBM is directly or indirectly conducting
business.

3.0 MUTUAL RESPONSIBILITIES

3.1 Each party will name a focal point to coordinate, among other things, joint
marketing opportunities for the Solution. The focal points shall identify any
impediments to the success of this relationship and institute an appropriate
action plan to remove such impediments. The focal points will confer on a
regular basis (but not less than once per quarter) to jointly assess status and
progress under this Agreement.

3.2 Each party will identify a technical coordinator ("Technical Coordinator")
who will coordinate technical activities relative to Enabling your Products to
the IBM technologies in Section 4.2.

3.3 The parties agree to market the Solution to the Joint Account List as
identified in Exhibit A of this Agreement. The Joint Account List may be updated
by mutual consent. A named focal point will provide the necessary customer
information to either add an account or delete an account by e-mail to the named
focal point of the other party. Acceptance by return e-mail is required for the
update to take effect.

3.4 The parties will jointly develop a sales and marketing enablement plan
within 60 days after signing this Agreement. Such plan will address sales
teaming activities in support of generating leads for the Solution. The parties
also agree to discuss, if the milestones in this Agreement are met, expanding
the scope of this relationship including enablement to additional IBM
technologies and increasing IBM market share.

4.0 YOUR RESPONSIBILITIES

4.1 You will lead with IBM technologies and services in your marketing and sales
activities.

4.2 You shall Enable to the IBM technologies as specified in the table below.
Prior to GA, you agree to keep your IBM focal point apprised of your Enablement
progress, status and milestones on a monthly basis. Once Enabled (or if you are
already Enabled), you agree to stay technically current on the IBM platform(s),
where applicable.

                                       2
<PAGE>

<TABLE>
<CAPTION>
             YOUR PRODUCTS                         IBM TECHNOLOGY                GENERAL AVAILABILITY DATE
<S>                                         <C>                                       <C>
          TurboWorx Enterprise                        TSpaces                           GA July 2004
          TurboWorx Enterprise                          DB2                              June, 2005
          TurboWorx Enterprise              WebSphere Application Server              September, 2005
          TurboWorx Enterprise              iSeries w/Linux RH EL AS 3.0                GA July 2004
          TurboWorx Enterprise                    pSeries w/AIX 5.2                     GA July 2004
          TurboWorx Enterprise               pSeries w/Linux SuSE Sles8                 GA July 2004
          TurboWorx Enterprise              zSeries w/Linux RH EL as 3.01               GA July 2004
          TurboWorx Enterprise              xSeries w/Linux RH EL AS 3.01               GA July 2004
          TurboWorx Enterprise               xSeries w/Windows 2003, XP                 GA July 2004
          TurboWorx Enterprise              IBM FASt T600 Storage device                GA July 2004

       TurboWorx ClusterManager             WebSphere Application Server              September, 2005
</TABLE>

4.3 You agree to provide a minimum of three (3) customer references for the
Solution. A customer reference is considered fully provided when it is formally
accepted for accepted for inclusion in the IBM customer reference database that
is accessible through the IBM PartnerWorld for Developers web site at
http://www.developer.ibm.com/marketing/member/cust_ref_db.html.

4.4 You will make commercially reasonable efforts to achieve the following
milestone measurements that demonstrate market traction for the Solution.

<TABLE>
<CAPTION>
------------------------------------------------------------------------------------------------------------------
          NAME OF ISV SOLUTION                  MILESTONE                      MILESTONE REACHED BY
------------------------------------------------------------------------------------------------------------------
<S>                                           <C>                     <C>
          TurboWorx Enterprise                20 proposals            One year after effective contract date
                                         -------------------------------------------------------------------------
                                                3 proposals                  End of Q1 in contract year
                                         -------------------------------------------------------------------------
                                                5 proposals                          End of Q2
                                         -------------------------------------------------------------------------
                                                6 proposals                          End of Q3
                                         -------------------------------------------------------------------------
                                                6 proposals                          End of Q4
------------------------------------------------------------------------------------------------------------------
          TurboWorx Enterprise                  7 pilots:            One year after effective contract date:
                                         -------------------------------------------------------------------------
                                                  1 pilot                    End of Q1 in contract year
                                         -------------------------------------------------------------------------
                                                  1 pilot                            End of Q2
                                         -------------------------------------------------------------------------
                                                 2 pilots                            End of Q3
                                         -------------------------------------------------------------------------
                                                 3 pilots                            End of Q4
------------------------------------------------------------------------------------------------------------------
          TurboWorx Enterprise            Total:4 closed deals        One year after effective contract date
------------------------------------------------------------------------------------------------------------------

------------------------------------------------------------------------------------------------------------------
        TurboWorx ClusterManager                10 trials             One year after effective contract date

                                         -------------------------------------------------------------------------
                                                  1 trial                    End of Q1 in contract year
                                         -------------------------------------------------------------------------
                                                 2 trials                            End of Q2
                                         -------------------------------------------------------------------------
                                                 3 trials                            End of Q3
                                         -------------------------------------------------------------------------
                                                 4 trials                            End of Q4
------------------------------------------------------------------------------------------------------------------
        TurboWorx ClusterManager          Total: 5 closed deals           One year after effective date

------------------------------------------------------------------------------------------------------------------
</TABLE>

You will provide IBM evidence of completion of these milestones at IBM's
request.

4.5 If requested by IBM, you will provide IBM with a reasonable number of
demonstration copies of your Enabled Products at no charge solely for IBM's
marketing and demonstration activities under this Agreement or use in IBM
Innovation Centers.

4.6 You will work with the other members of the Global Grid Forum grid technical
community on defining and establishing the Open Grid Services Architecture
(OGSA) as an industry standard. Once OGSA is adopted as an

                                       3
<PAGE>

industry standard (published as a standard by a responsible industry standards
body, such as, but not limited to, GGF, IETF, OASIS, W3C, WSRF), where
applicable and mutually agreeable, you will adhere to OGSA and will develop OGSA
Grid Service interfaces to their important functions in addition to, or in lieu
of, existing interfaces. Also, where applicable, you will exploit the OGSA
infrastructure (OGSI) services as the fundamental, system-independent Grid
Computing environment to permit portability and interoperability.

5.0 IBM'S RESPONSIBILITIES

5.1 IBM, in its discretion, will provide the following co-marketing assistance:

     i.   IBM will provide you with access to information regarding our
          offerings via web sites, technical conferences and literature;

     ii.  IBM will communicate the existence of this Agreement and marketing
          relationship via e-mail to our in-country distribution;

     iii. IBM will include your material and/or personnel in its Think Grid
          Workshops and other ISV-specific outreach programs;

     iv.  IBM (through its Grid Sales Team) will participate in mutual training
          with you for the digital content creation and/or business intelligence
          vertical markets.

5.2 IBM will include a reference and description of your Enabled Product(s) (you
will provide the description) in its Global Solutions Directory. This directory
is intended to afford you an opportunity to market your Enabled Product(s) on a
global scale. It includes direct links from IBM to your website, and enables you
to customize your listing with your company and contact information, your
logo(s) and certification mark(s), as applicable. You will obtain all necessary
approvals for any third party information that you provide, and hereby authorize
IBM to publicly publish this information as we deem appropriate.

5.3 IBM will identify your company as having an IBM marketing relationship in
our internal sales tool and may publish customer references on our internal
websites (e.g., eBusiness Advisor).

5.4 IBM will enroll you in the IBM "Innovate Now" program and will provide you
benefits such as:

     i.   IBM Software Access Option (provides you access to IBM's Software
          Access Catalog through which you may obtain a limited number of
          discounted CDs and no-charge downloads of IBM software)

     ii.  Access to IBM Innovation Centers ("IICs"), subject to scheduling and
          hardware availability and at no charge to you, in support of your
          Enablement efforts as set forth herein

     iii. Out-of-the-box marketing campaigns

6.0 TERM AND TERMINATION - This Agreement is effective once signed by you and
IBM and will remain in effect for one (1) year. After GA, either of us may
terminate this Agreement for convenience with 90 days prior written notice.
Either of us may terminate this Agreement on 30 days' written notice if the
other materially breaches its obligations unless the breach is corrected within
the 30 day notice period. Any terms of this Agreement which by their nature
extend beyond the day this Agreement ends remain in effect until fulfilled, and
apply to either of our successors and assignees.

7.0 INFORMATION - Unless we mutually agree to exchange confidential information
under a separate confidentiality agreement, all information we exchange is
non-confidential. However, both of us agree not to disclose the terms of this
Agreement to a third party without the other's prior written consent, except as
required by law.

8.0 PUBLICITY - You agree to publicly endorse an open integrated solution
strategy built on IBM technology. In addition, you agree to allow IBM to make
public statements about your endorsement of open standards and your intention to
Enable to IBM middleware (and Linux, where applicable). Once you have Enabled
and we have achieved customer wins in the marketplace, we will jointly look for
opportunities to announce or publicize our success in the marketplace.
Otherwise, neither of us will issue press releases or other publicity regarding
this Agreement or this relationship without the other's prior written approval.

9.0 PRIVACY - We both have the right to store contact information on each
other's employees such as names, phone numbers and e-mail addresses in any
country where we do business. Each of us may use such

                                       4
<PAGE>

information to fulfill our respective obligations under this Agreement, subject
to any signed confidentiality agreement between us.

10.0 LIMITATION OF LIABILITY - Neither of us will be liable to the other for any
economic consequential damages (including lost profits or savings) or incidental
damages under this Agreement, even if advised that they may occur. Each of our
liability for any claim under this Agreement will be limited to actual damages
up to US$50,000.

11.0 ASSIGNMENT - Each party may only assign this Agreement to a subsidiary or
in connection with the sale of all or a substantial portion of its business. Any
other attempted assignment is void. Notwithstanding any other term herein,
either party may terminate this Agreement on thirty days written notice to the
other party if the other party assigns this Agreement to an entity the other
party reasonably deems a competitor.

12.0 GENERAL - Except where specified herein, each party is responsible for its
own costs under this Agreement, including all business, travel and living
expenses. Neither party will bring a legal action against the other more than
two years after the cause of action arose. Each party waives its right to a jury
trial in any dispute. Failure by either party to demand strict performance or to
exercise a right does not prevent either party from doing so later. The parties
are independent contractors. Personnel supplied by either party are not for any
purpose considered employees or agents of the other party. Each party assumes
full responsibility for the actions of its personnel while performing its
obligations under this Agreement and is solely responsible for their direction
and compensation. This Agreement does not create any obligations for the parties
in any way limiting or restricting the assignment of its respective employees.
This is a non-exclusive relationship. Each party may have similar agreements
with others and may independently develop, acquire, and market materials,
equipment, or programs that may be competitive with (despite any similarity to)
the other party's products or services. The laws of New York govern this
Agreement.

                                       5
<PAGE>

EXHIBIT A - JOINT ACCOUNT LIST

JOINT ACCOUNT LIST shall mean a list prepared by you and IBM which identifies
the customers to whom both parties agree to market the Solution. Such list shall
include, without limitation, the customer name and address, each party's account
representative (s) assigned to the account, a description of and the estimated
size of the opportunity and the opportunity's IBM technology components.

<TABLE>
<CAPTION>
-------------------- ------------------ ------------------------- --------------- -------------- ------------------
       NAME               ADDRESS        ACCOUNT REPRESENTATIVE    OPPORTUNITY     OPPORTUNITY    IBM TECHNOLOGY
                                                                   DESCRIPTION        SIZE
-------------------- ------------------ ------------------------- --------------- -------------- ------------------
<S>                  <C>                    <C>
  Univ. of Texas,    10100 Burnet Rd.         Ashok Adiga
      Austin         Austin, TX 78758
-------------------- ------------------ ------------------------- --------------- -------------- ------------------
      Protana         480 University         Moyez Dharsee
                          Avenue
                         Suite 401
                      Toronto, ON M5G
                            1V2
                          Canada
-------------------- ------------------ ------------------------- --------------- -------------- ------------------
   George Tech.       315 Ferst Drive      Ajit P. Yoganathan
                        Atlanta, GA
                        30332-0363
-------------------- ------------------ ------------------------- --------------- -------------- ------------------
      Aventis          Poseidon Haus     Karl-Heinz Baringhaus
                       Frankfurt am
                       Main, D-65926
                          Germany
-------------------- ------------------ ------------------------- --------------- -------------- ------------------
    AstraZeneca        35 Gatehouse          Mark Duffield
                           Drive
                     Waltham, MA 02451
-------------------- ------------------ ------------------------- --------------- -------------- ------------------
 Marsh & McLennan     1166 Avenue of       Sandeep Manchanda
                       the Americas,
                       New York, NY
                        10036-2774
-------------------- ------------------ ------------------------- --------------- -------------- ------------------
</TABLE>

                                       6EXHIBIT 10.15

         THE SECURITIES REPRESENTED HEREBY HAVE BEEN ACQUIRED BY THE HOLDER
NAMED HEREON FOR ITS OWN ACCOUNT FOR INVESTMENT WITH NO INTENTION OF MAKING OR
CAUSING TO BE MADE ANY PUBLIC DISTRIBUTION OF ALL OR ANY PORTION THEREOF; AND
SUCH SECURITIES MAY NOT BE PLEDGED, SOLD OR IN ANY OTHER WAY TRANSFERRED IN THE
ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR SUCH SECURITIES UNDER THE
SECURITIES ACT OF 1933, AS IN EFFECT AT THAT TIME OR AN OPINION OF COUNSEL
REASONABLY SATISFACTORY TO THE ISSUER THAT REGISTRATION IS NOT REQUIRED UNDER
SAID ACT.

Warrant No. 2000 -
                   --------

                             STOCK PURCHASE WARRANT

                           To Subscribe for Shares of

                                      Stock

                                       of

                               TurboGenomics, Inc.

         THIS CERTIFIES THAT, for value received, (the "holder"), is entitled to
subscribe for and purchase from TurboGenomics, Inc. (the "Company") that number
of shares of the Company's equity securities described herein [as defined in
Section 9(a), the "Stock"] calculated in accordance with Section 1 hereof at a
price per share calculated in accordance with Section 2 hereof (with adjustments
provided for herein, the "Warrant Price") at any time from the date hereof to
and including the earlier to occur of (i) February ____, 2009; and (ii) the date
on which the Company consummates an initial public offering of its capital stock
registered under the Securities Act of 1933, as amended, subject to the terms
and conditions stated in this Warrant (the "Warrant").

         This Warrant is one of a series of Stock Purchase Warrants ("Purchase
Warrants") issued in conjunction with a financing commenced by the Company in
December 2000 consisting of convertible notes issued by the Company
(collectively the "Notes") of a maximum amount of $3,000,000.

<PAGE>

         1.       NUMBER OF SHARES OF STOCK

         The number of shares of Stock the holder hereof is entitled to
subscribe for and purchase from the Company shall be determined by dividing the
principal amount of the note $______ with which this Warrant was issued by four
(4) and dividing the sum so arrived at by the Exercise Price set forth in
Section 2 hereof.

         2.       EXERCISE PRICE

         The exercise price per share to be paid to the Company for the Stock to
which that holder hereof has the right to subscribe shall be determined by (i)
the purchase price per share of equity in the next round of financing raised by
the Company if such equity is common stock or debt convertible into common
stock, or the purchase price per share of equity in the next round of financing
raised by the Company if such equity is Preferred Stock or debt convertible into
or with a right to buy Preferred Stock attached, provided however in either case
a minimum of $5,500,000 is raised (the "Financing"), or (ii) in the event the
Company does not close the Financing by March 31, 2003, $0.50 per share as
adjusted as provided herein.

         3.       EXERCISE OF WARRANT

         The rights represented by this Warrant may be exercised by the holder
after the earlier to occur of (i) the closing by the Company of the Financing,
or (ii) March 31, 2003, in whole or in part by the surrender of this Warrant and
delivery of an executed Exercise Notice in the form attached hereto to the
Company at its principal office at any time or times within the period specified
above, accompanied by payment for the Stock so subscribed for by certified or
bank check. In the event of the partial exercise of the rights represented by
this Warrant, a new Warrant representing the number of shares as to which this
Warrant shall not have been exercised shall be promptly issued to the holder. In
any event, such a new Warrant and a certificate or certificates for the Stock
purchased shall be delivered by the Company to the holder not later than ten
days after payment is made for the purchased Stock.

         4.       VALIDITY OF ISSUE

         The Company warrants and agrees that all shares of Stock which may be
issued upon the exercise of the rights represented by this Warrant will, upon
issuance, be fully paid and nonassessable and free from all taxes, liens and
charges with respect to the issue thereof. The Company further warrants and
agrees that during the period within which the rights represented by this
Warrant may be exercised, the Company will at all times have authorized and
reserved a sufficient number of shares of Stock to provide for the exercise of
the rights represented by this Warrant.

         5.       ADJUSTMENTS TO PREVENT DILUTION

         (a) If and whenever the Company shall issue or sell any shares of Stock
for a consideration per share less than the Warrant Price in effect immediately
prior to the time of such issue or sale, then upon such issue or sale, the
Warrant Price shall be recalculated (and if applicable reduced, but in no event
thereby increased) to a price (calculated to the nearest cent) determined by
dividing (i) an amount equal to the sum of (aa) the number of shares of Stock

<PAGE>

outstanding immediately prior to such issue or sale multiplied by the then
existing Warrant Price, and (bb) the consideration, if any, received by the
Company upon such issue or sale by (ii) the total number of shares of Stock
outstanding immediately after such issue or sale.

                  (1) If at any time the Company shall in any manner grant any
options or rights to subscribe for or to purchase Stock or securities
convertible into Stock ("Convertible Securities") or shall issue or sell any
Convertible Securities and the price per share for which Stock is issuable upon
the exercise of such rights or options or upon conversion or exchange of such
Convertible Securities [determined by dividing (i) the total amount, if any,
received or receivable by the Company as consideration for the granting of such
rights or options or for the issuance or sale of Convertible Securities, plus
the minimum aggregate amount of additional consideration payable to the Company
upon the exercise of such rights or options, plus, in the case of such
Convertible Securities, the minimum aggregate amount of additional
consideration, if any, payable upon the conversion or exchange thereof, by (ii)
the total maximum number of shares of Stock issuable upon the exercise of such
rights or options or upon the conversion or exchange of such Convertible
Securities] shall be less than the Warrant Price in effect immediately prior to
the time of the granting of such rights or options or the issuance or sale of
such Convertible Securities, then the total maximum number of shares of Stock
issuable upon the exercise of such rights or options or upon conversion or
exchange of such Convertible Securities shall (as of the date of granting of
such rights or options or the issuance or sale of such Convertible Securities)
be deemed to be outstanding and to have been issued for such price per share. No
further adjustments of the Warrant Price shall be made upon the actual issue of
such Stock or of such Convertible Securities upon exercise of such rights or
options or upon the actual issue of such Stock upon conversion or exchange of
such Convertible Securities. Unless a provision of any other paragraph of this
Section 4 controls, if the price per share for which Stock is issuable upon
exercise of such rights or options or upon conversion or exchange of such
Convertible Securities shall change at any time, the Warrant Price then in
effect shall forthwith be adjusted or readjusted to such Warrant Price as would
have obtained had the adjustments made upon the issuance or sale of such rights,
options or Convertible Securities been made upon the basis of (a) the issuance
of the number of shares of Stock theretofore actually delivered (and the total
consideration received therefor) upon the exercise of such options or rights or
upon the conversion or exchange of such Convertible Securities, and (b) the
assumption that the remaining outstanding options, rights, or Convertible
Securities were originally issued at the time of such change. On the expiration
of any such option or right or the termination of any such right to convert or
exchange such Convertible Securities, the Warrant Price then in effect shall
forthwith be readjusted to such Warrant Price as would have obtained had the
adjustments made upon the issuance or sale of such rights or options or
Convertible Securities been made upon the basis of (a) the issuance of the
number of shares of Stock theretofore actually delivered (and the total
consideration received therefor) upon the exercise of such rights or options or
upon the conversion or exchange of such Convertible Securities and (b) the
issuance or sale of any such options, rights or Convertible Securities as remain
outstanding after said expiration or termination.

                  (2) If the Company shall declare a dividend, or make any
further distribution upon any capital stock of the Company, payable in Stock or
Convertible Securities, then any Stock or Convertible Securities (as the case
may be) issuable in payment of such dividend or

<PAGE>

distribution shall be deemed to have been issued or sold without consideration;
and in addition to the adjustment of the Warrant Price required by this Section
4(a), the number of shares of Stock issuable upon exercise of this Warrant shall
be proportionately increased so that the holder upon exercise of this Warrant
shall be entitled to receive the same number of shares of Stock which it would
have received if it had exercised this Warrant in full immediately prior to the
date for determining stockholders entitled to receive such dividend or
distribution.

                  (3) If any shares of Stock or Convertible Securities or any
rights or options to purchase any such Stock or Convertible Securities shall be
issued for cash, then the consideration received shall be deemed to be the
amount received by the Company, without deduction therefrom of any expenses
incurred or any underwriting commissions or concessions paid or allowed by the
Company in connection therewith. In case any shares of Stock or Convertible
Securities or any rights or options to purchase any such Stock or Convertible
Securities shall be issued for a consideration other than cash, the amount of
the consideration other than cash received by the Company shall be deemed to be
the value of such consideration as determined by the Board of Directors of the
Company, without deduction of any expenses incurred or any underwriting
commissions or concessions paid or allowed by the Company in connection
therewith.

                  (4) If the Company shall take a record of the holders of its
Stock for the purpose of entitling them (i) to receive a dividend or other
distribution payable in Stock or in Convertible Securities, or (ii) to subscribe
for or purchase Stock or Convertible Securities, then for purposes of this
Warrant such record date shall be deemed to be the date of the issue or sale of
the shares of Stock deemed to have been issued or sold upon the declaration of
such dividend or the making of such other distribution or the date of the
granting of such right of subscription or purchase, as the case may be.

         (b) If the Company shall declare a dividend upon any Stock of the
Company payable otherwise than as a cash dividend paid out of current earnings,
or in Stock or Convertible Securities, then the Warrant Price in effect
immediately prior to the declaration of such dividend shall be reduced by an
amount equal to the fair value of the dividend per share of the Stock
outstanding at the time of such declaration as determined by the Board of
Directors of the Company. Such reduction shall take effect as of the date on
which a record is taken for the purpose of such dividend or, if a record is not
taken, the date as of which the holders of Stock of record entitled to such
dividend are to be determined.

         (c) If the Company shall at any time subdivide its outstanding shares
of Stock into a greater number of shares, then the Warrant Price in effect
immediately prior to such subdivision shall be proportionately reduced, and the
number of shares issuable upon exercise of this Warrant shall be proportionately
increased; and conversely, in case the outstanding shares of Stock of the
Company shall be combined into a smaller number of shares, the Warrant Price in
effect immediately prior to such combination shall be proportionately increased
and the number of shares issuable proportionately reduced.

         (d) Except as provided in paragraph (c) of this Section, if any capital
reorganization or reclassification of the capital stock of the Company, or
consolidation or merger of the

<PAGE>

Company with another corporation, or the sale of all or substantially all of its
assets or of any successor corporation's property and assets to any other
corporation or corporations (any such corporation being included within the
meaning of the term "successor corporation") shall be effected, then as a
condition of such recapitalization, reclassification, consolidation, merger, or
conveyance, lawful and adequate provision shall be made whereby the holder shall
thereafter have the right to purchase and receive upon the basis and upon the
terms and conditions specified in this Warrant and in lieu of the shares of
Stock of the Company immediately theretofore purchasable and receivable upon the
exercise of the right represented hereby, such shares of stock, securities or
assets as may be issued or payable with respect to or in exchange for a number
of outstanding shares of such Stock equal to the number of shares of such Stock
immediately theretofore purchasable and receivable upon the exercise of the
rights represented hereby had such recapitalization, reclassification,
consolidation, merger or conveyance not taken place, and in any such case
appropriate provisions shall be made with respect to the rights and interests of
the holder of this Warrant to the end that the provisions hereof (including
without limitation provisions for adjustment of the warrant price and of the
number of shares purchasable upon the exercise of this warrant) shall thereafter
be applicable, as nearly as may be, in relation to any shares of stock,
securities or assets thereafter deliverable upon the exercise hereof. Except as
hereinafter provided, the Company shall not effect any consolidation or merger
unless prior to the consummation thereof the successor corporation shall assume
by written instrument executed and mailed to the holder at its address
registered on the books of the Company the obligation to deliver to the holder
such shares of stock, securities or assets as, in accordance with the foregoing
provisions, such holder may be entitled to purchase. Notwithstanding the
foregoing, in the event of a merger or consolidation in which the Company is not
the surviving entity, if the Company concludes that it will be unable to satisfy
the conditions of this paragraph without a material adverse effect on the terms
of such proposed transaction, then the Company shall have the option, prior to
or contemporaneously with the closing of such merger or consolidation, to
purchase the Warrant from the holder at its then fair value, having regard to
both the spread between the Warrant Price and the value of the consideration to
be received in the transaction and the remaining term of the Warrant. The
Company and the holder of the Warrant shall agree on such fair value or, in the
event they are unable to agree, shall submit the question of fair value to
binding arbitration before a single arbitrator sitting in New Haven,
Connecticut, under the commercial rules of the American Arbitration Association
(any cost of arbitration to be borne by the Company).

         (e) Upon any adjustment of the Warrant Price, then and in each such
case the Company shall give written notice thereof, by first class mail, postage
prepaid, addressed to the holder of this Warrant at its address registered on
the books of the Company, which notice shall state the Warrant Price resulting
from such adjustment and the increased or decreased, if any, number of shares
purchasable at such price upon the exercise of this Warrant, setting forth in
reasonable detail the method of calculation and the facts upon which such
calculation is based.

         (f) This Section 5 shall not apply to the issuance of Stock, or options
therefor, (i) in connection with the Financing, (ii) to officers or employees
of, or consultants to, the Company pursuant either to the Company's 2000 Stock
Plan, including amendments thereto, or to future stock plans of like kind, all
such amendments or plans as approved by a majority of the Board of Directors of
the Company and subject to an aggregate cap of 2,250,000 shares as adjusted for

<PAGE>

splits, combinations, and reclassifications, and (iii) to officers or employees
of, or consultants to, the Company pursuant to any agreements for Stock
heretofor granted by the Company.

         6.       NOTICE OF REORGANIZATIONS, ETC.

         In case at any time:

         (a) there shall be any capital reorganization, or reclassification of
the capital stock of the Company, or consolidation or merger of the Company with
another corporation; or

         (b) there shall be a voluntary or involuntary dissolution, liquidation
or winding up of the Company; then, in each one or more of said cases, the
Company shall give at least the same notice as is provided to the Company's
shareholders, by first class mail, postage prepaid, addressed to the holder at
its address registered on the books of the Company of (i) the date on which the
books of the Company shall close or a record shall be taken for purposes of
ascertaining which shareholders will be entitled to vote on such
reclassification, reorganization, consolidation, merger, dissolution,
liquidation or winding up, as the case may be; (ii) the date on which the vote
shall be taken concerning such reclassification, reorganization, consolidation,
merger, dissolution, liquidation or winding up, as the case may be; and (iii)
the date on which such reclassification, liquidation or winding up, as the case
may be, is to be effective. Such notice shall also specify the date as of which
the holders of Stock of record shall be entitled to exchange their Stock for
securities or other property deliverable upon such reorganization,
reclassification, consolidation, merger, dissolution, liquidation, or winding
up, as the case may be.

         7.       ISSUANCE OF ADDITIONAL STOCK

         The Company shall give to the holder at least the same notice as is
provided to the Company's shareholders, by first class mail, postage prepaid,
addressed to the holder at its address registered on the books of the Company,
of the record date for determining the holders of Stock who shall be granted
rights as a class to subscribe for or to purchase, or any options for the
purchase of, Stock or Convertible Securities, to the end that the holder may
exercise its rights to acquire Stock under this Warrant, by delivery of an
executed Exercise Notice in accordance with Section 3 prior to said record date,
and may thereby receive the same rights as other holders of Stock on said record
date.

         8.       INVESTMENT REPRESENTATION

         The holder by accepting this Warrant represents that the Warrant is
acquired for the holder's own account for investment purposes and not with a
view to any offering or distribution and that the holder has no present
intention of selling or otherwise disposing of the Warrant or the underlying
shares of Stock. Upon exercise, the holder will confirm, in respect of
securities obtained upon such exercise, that it is acquiring such securities for
its own account and not with a view to any offering or distribution in violation
of applicable securities laws.

<PAGE>

         9.       MISCELLANEOUS

         (a) As used herein the term "Stock" shall mean (i) if the Financing is
consummated on or before March 31, 2003, the type of equity securities sold in
the Financing; or (ii) if the Financing is not consummated on or before March
31, 2003, the Company's presently authorized Common Stock, $.001 par value, and
stock of any other class into which such presently authorized Stock may
hereafter be changed. For the purposes of Sections 5, the term "Stock" shall
also include any capital stock of any class of the Company hereafter authorized
which shall not be limited to a fixed sum or percentage in respect of the rights
of the holders thereof to participate in dividends or in the distribution of
assets upon the voluntary or involuntary liquidation, dissolution or winding up
of the Company.

         (b) This Warrant shall not entitle the holder to any voting rights or
other rights as a stockholder of the Company, or to any other rights whatsoever
except the rights herein expressed, and no cash dividend paid out of earnings or
surplus or interest shall be payable or accrue in respect of this Warrant or the
interest represented hereby or the shares which may be subscribed for any
purchased hereunder until and unless and except to the extent that the rights
represented by this Warrant shall be exercised.

         (c) This Warrant is exchangeable, upon the surrender hereof at the
office or agency of the Company, for new Warrants of like tenor representing in
the aggregate the right to subscribe for and purchase the number of shares which
may be subscribed for and purchased hereunder, each of such new Warrants to
represent the right to subscribe for and purchase each number of shares as shall
be designated by said holder at the time of such surrender.

         (d) The Purchase Warrants and any terms thereof may be changed, waived,
discharged or terminated only by an instrument in writing signed by the holders
of at least sixty-six and 2/3 percent (66-2/3%) of the Stock issuable upon
exercise of the Purchase Warrants. This Warrant shall be construed and enforced
in accordance with and governed by the internal laws of the State of
Connecticut. The descriptive headings of the several sections and paragraphs in
this Warrant are for purposes of reference only, and shall not limit or
otherwise affect any of the terms hereof. The invalidity or unenforceability of
any provision hereof shall in no way affect the validity or enforceability of
any other provision.

         (e) Fractional shares shall not be issued upon the exercise of this
Warrant, but in any case where the holder would, except for the provisions of
this Section 9(e), be entitled under the terms hereof to receive a fractional
share upon the complete exercise of this Warrant, the Company shall, upon the
exercise of this Warrant for the largest number of whole shares then called for,
cancel this Warrant and pay a sum in cash equal to the value of such fractional
share (determined in such reasonable manner as may be prescribed in good faith
by the Board of Directors of the Company).

         (f) If this Warrant is lost, stolen, mutilated or destroyed, the
Company may, on such terms as to indemnity or otherwise as it may in its
discretion impose (which shall, in the case of a mutilated Warrant, include the
surrender thereof), issue a new Warrant of like denomination and tenor as the
Warrant so lost, stolen, mutilated or destroyed. Any such new Warrant shall

<PAGE>

constitute an original contractual obligation of the Company, whether or not the
allegedly lost, stolen, mutilated or destroyed Warrant shall be at any time
enforceable by anyone.

         10. TRANSFER AND REGISTRATION

         (a) If any proposed transfer, in whole or in part, of this Warrant or
the Stock issuable upon exercise of this Warrant might reasonably involve a
public offering of the same contrary to the investment representations in
Section 8, the Company may require, as a condition precedent to such transfer,
an opinion of counsel, satisfactory to it, that the proposed transfer will not
involve a public offering which is required to be registered under the
Securities Act of 1933. However, no such requirement shall be imposed during
such time as a new registration statement or a post-effective amendment thereof
covering the Stock or part thereof being transferred is in effect. Subject to
the foregoing, this Warrant and all rights hereunder is transferable, in whole
or in part, on the books of the Company to be maintained for such purpose, upon
surrender of this Warrant at the principal office of the Company, together with
a written assignment of this Warrant duly executed by the holder or its agent or
attorney.

         (b) This Warrant and the name and address of the holder have been
registered in a Warrant Register that is kept at the principal office of the
Company, and the Company may treat the holder so registered as the absolute
owner of this Warrant for all purposes.

                     [THIS SPACE INTENTIONALLY LEFT BLANK.]

<PAGE>

         IN WITNESS WHEREOF, the Company has caused this Warrant to be signed by
its President and Treasurer and its corporate seal to be hereunto affixed, and
attested by its Secretary on this ____ day of ________, 2002.

                                             TURBOGENOMICS, INC.

                                             By:
                                                --------------------------------
                                             Name:

(SEAL)

Attest:

----------------------------
Beverly E. Thalberg, Secretary

<PAGE>

                                 EXERCISE NOTICE

TO:  TURBOGENOMICS, INC.

         The undersigned owner of the accompanying Warrant hereby irrevocably
exercises the option to purchase _____ shares of Common Stock in accordance with
the terms of such Warrant, directs that the shares issuable and deliverable upon
such purchase (together with any check for a fractional interest) be issued in
the name of and delivered to the undersigned, and makes payment in full therefor
at the Warrant Price provided in such Warrant.

COMPLETE FOR REGISTRATION OF SHARES OF COMMON STOCK ON THE STOCK TRANSFER
RECORDS MAINTAINED BY THE COMPANY:

----------------------------------------------------------------
Name of Warrant Holder

----------------------------------------------------------------
Address

----------------------------------------------------------------
Social Security or Federal Identification Number

Signature:
          -------------------------------

Date:
     ------------------------------------

<PAGE>

                                   ASSIGNMENT

         FOR VALUE RECEIVED ___________________________________ hereby sells,
assigns and transfers all of the rights of the undersigned under the within
Warrant, with respect to the number of shares of the Common Stock covered
thereby set forth hereinbelow, unto

                                                Social Security
                                                or Federal             No.
Name of                                         Identification         of
Assignee     Address                            Number                 Shares
--------     -------                            ------                 ------

Signature:
              ------------------------

Address:
              ------------------------

              ------------------------

              ------------------------

Date:
              ------------------------

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00085-of-00352.parquet"}]]